Cryo-cell International Share Price Today
(NASDAQ: CCEL)

Name: Cryo-cell International Share Price Today (NASDAQ: CCEL) - Cryo-cell International Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Cryo-cell International share price is $7.12 & ₹619.22 as on 6 Mar 2025, 2.30 'hrs' IST

$7.12

▲

0.52

(7.88%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cryo-cell International share price in Dollar and Rupees. Guide to invest in Cryo-cell International stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cryo-cell International, along with analyst recommendations, forecasts, and comprehensive financials.

Cryo-cell International share price movements

Today's Low: $6.31
Today's High: $7.31
$7.12
11.38%
Downside
Day's Volatility :13.68%
Upside
2.6%
52 Weeks Low: $5.12
52 Weeks High: $9.50
$7.12
28.09%
Downside
52 Weeks Volatility :46.09%
Upside
25.04%

Cryo-cell International (CCEL) Returns

Period	Cryo-cell International Inc	Index (Russel 2000)
3 Months	-25.51%	0.0%
6 Months	2.7%	0.0%
1 Year	19.78%	0.0%
3 Years	-18.52%	-11.6%

Cryo-cell International (CCEL) Key Statistics

in dollars & INR

Previous Close	$6.6
Open	$6.75
Today's High	$7.31
Today's Low	$6.31
Market Capitalization	$53.2M
Today's Volume	$1.9K
52 Week High	$9.498
52 Week Low	$5.1202
Revenue TTM	$31.8M
EBITDA	$641.3K
Earnings Per Share (EPS)	$0.05
PE Ratio	132.0
Dividend Yield	12.66%
Profit Margin	-28.04%
Quarterly Earnings Growth YOY	0.63%
Return On Equity TTM	129.2%

How to invest in Cryo-cell International Stock (CCEL) from India?

It is very easy for Indian residents to invest directly in Cryo-cell International from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cryo-cell International stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cryo-cell International or CCEL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cryo-cell International or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cryo-cell International shares which would translate to 0.122 fractional shares of Cryo-cell International as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cryo-cell International, in just a few clicks!

Returns in Cryo-cell International (CCEL) for Indian investors in Rupees

The Cryo-cell International stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Cryo-cell International investment value today

Current value as on today

₹1,34,182

Returns

₹34,182

(+34.18%)

Returns from Cryo-cell International Stock

₹29,220 (+29.22%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Cryo-cell International (CCEL)

-29%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cryo-cell International Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cryo-cell International

Hamilton Lane Advisors LLC
5.08%
SFI Advisors, LLC
2.05%
Vanguard Group Inc
1.45%
MASSMUTUAL TRUST CO FSB/ADV
1.38%
Geode Capital Management, LLC
0.49%
Northern Trust Corp
0.48%

Analyst Recommendation on Cryo-cell International

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Cryo-cell International(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cryo-cell International Stock (CCEL)

What analysts predicted

Upside of 19.38%

Target:

$8.50

Current:

$7.12

Insights on Cryo-cell International Stock (Ticker Symbol: CCEL)

Price Movement
In the last 7 days, CCEL stock has moved down by -13.0%
Decreasing Revenue
Revenue is down for the last 2 quarters, 8.06M → 8.02M (in $), with an average decrease of 0.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 1.05M → -1.86M (in $), with an average decrease of 277.0% per quarter
CCEL vs THC (1 yr)
In the last 1 year, Tenet Healthcare Corp. has given 28.4% return, outperforming this stock by 11.6%
CCEL vs THC (3 yr)
In the last 3 years, Tenet Healthcare Corp. has given 34.6% return, outperforming this stock by 53.7%
Price to Sales
ForCCEL every $1 of sales, investors are willing to pay $1.7, whereas for Tenet Healthcare Corp. , the investors are paying $0.6 for every $1 of sales.

CCEL Cryo-cell International Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$31.8M	↑ 8.89%
Net Income	$2.3M	↓ 367.98%
Net Profit Margin	7.2%	↑ 10.13%

	FY20	Y/Y Change
Revenue	$31.1M	↓ 2.1%
Net Income	$3.6M	↑ 58.23%
Net Profit Margin	11.64%	↑ 4.44%

	FY21	Y/Y Change
Revenue	$28.9M	↓ 7.26%
Net Income	$2.1M	↓ 42.52%
Net Profit Margin	7.21%	↓ 4.43%

	FY22	Y/Y Change
Revenue	$30.3M	↑ 5.03%
Net Income	$2.8M	↑ 33.02%
Net Profit Margin	9.14%	↑ 1.93%

	FY23	Y/Y Change
Revenue	$31.3M	↑ 3.32%
Net Income	$-9.5M	↓ 443.57%
Net Profit Margin	-30.38%	↓ 39.52%

	FY24	Y/Y Change
Revenue	$32.0M	↑ 2.05%
Net Income	$5.2M	↓ 154.68%
Net Profit Margin	16.28%	↑ 46.66%

	Q3 FY23	Q/Q Change
Revenue	$7.9M	↑ 1.25%
Net Income	$680.6K	↑ 207.98%
Net Profit Margin	8.65%	↑ 5.81%

	Q4 FY23	Q/Q Change
Revenue	$7.9M	↑ 0.09%
Net Income	$-11.2M	↓ 1744.23%
Net Profit Margin	-142.06%	↓ 150.71%

	Q1 FY24	Q/Q Change
Revenue	$7.9M	↓ 0.31%
Net Income	$556.2K	↓ 104.97%
Net Profit Margin	7.08%	↑ 149.14%

	Q2 FY24	Q/Q Change
Revenue	$8.0M	↑ 2.43%
Net Income	$655.8K	↑ 17.9%
Net Profit Margin	8.15%	↑ 1.07%

	Q3 FY24	Q/Q Change
Revenue	$8.1M	↑ 0.3%
Net Income	$1.1M	↑ 60.37%
Net Profit Margin	13.04%	↑ 4.89%

	Q4 FY24	Q/Q Change
Revenue	$8.0M	↓ 0.53%
Net Income	$-1.9M	↓ 277.01%
Net Profit Margin	-23.2%	↓ 36.24%

	FY19	Y/Y Change
Profit	$21.8M	↑ 5.33%

	FY20	Y/Y Change
Profit	$21.5M	↓ 1.33%

	FY21	Y/Y Change
Profit	$19.9M	↓ 7.42%

	FY22	Y/Y Change
Profit	$21.5M	↑ 8.29%

	FY23	Y/Y Change
Profit	$22.9M	↑ 6.3%

	FY24	Y/Y Change
Profit	$24.0M	↑ 4.96%

	Q3 FY23	Q/Q Change
Profit	$5.7M	↑ 1.5%

	Q4 FY23	Q/Q Change
Profit	$5.8M	↑ 1.53%

	Q1 FY24	Q/Q Change
Profit	$5.7M	↓ 1.89%

	Q2 FY24	Q/Q Change
Profit	$6.0M	↑ 5.73%

	Q3 FY24	Q/Q Change
Profit	$5.9M	↓ 1.28%

	Q4 FY24	Q/Q Change
Profit	$6.4M	↑ 7.52%

	FY19	Y/Y Change
Operating Cash Flow	$6.3M	↑ 18.56%
Investing Cash Flow	$-690.7K	↓ 93.88%
Financing Cash Flow	$-5.1M	↓ 189.87%

	FY20	Y/Y Change
Operating Cash Flow	$8.5M	↑ 33.9%
Investing Cash Flow	$357.5K	↓ 151.76%
Financing Cash Flow	$-5.0M	↓ 2.49%

	FY21	Y/Y Change
Operating Cash Flow	$7.9M	↓ 6.38%
Investing Cash Flow	$-7.0M	↓ 2044.47%
Financing Cash Flow	$-3.1M	↓ 38.59%

	FY22	Y/Y Change
Operating Cash Flow	$8.6M	↑ 8.16%
Investing Cash Flow	$-15.3M	↑ 119.81%
Financing Cash Flow	$147.9K	↓ 104.81%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$1.9M	↓ 2.35%
Investing Cash Flow	$-3.4M	↑ 115.01%
Financing Cash Flow	$903.9K	↓ 236.28%

Cryo-cell International Technicals Summary

Sell

Neutral

Buy

Cryo-cell International is currently in a neutral trading position according to technical analysis indicators.

Cryo-cell International (CCEL) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cryo-cell International Inc	-15.82%	2.7%	19.78%	-18.52%	-43.1%
Fresenius Medical Care Ag	-7.04%	15.18%	13.92%	-21.11%	-38.54%
Hca Holdings, Inc.	-6.8%	-21.55%	-3.51%	20.1%	167.3%
Universal Health Services Inc.	-10.04%	-27.58%	-1.51%	15.21%	51.23%
Davita Healthcare Partners Inc.	-20.15%	-4.79%	7.3%	29.36%	83.43%
Tenet Healthcare Corp.	-14.64%	-24.27%	26.02%	40.79%	459.88%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cryo-cell International Inc	132.0	132.0	0.0	-0.08	1.29	0.0	0.13	-1.19
Fresenius Medical Care Ag	24.53	24.53	0.5	2.82	0.05	0.03	0.03	49.68
Hca Holdings, Inc.	14.15	14.15	0.99	24.92	0.82	0.11	0.01	-10.0
Universal Health Services Inc.	10.45	10.45	1.87	18.98	0.18	0.07	0.0	102.59
Davita Healthcare Partners Inc.	13.32	13.32	1.52	11.06	0.52	0.07	NA	1.5
Tenet Healthcare Corp.	3.75	3.75	0.54	11.89	0.58	0.07	NA	43.86

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cryo-cell International Inc	Buy	$53.2M	-43.1%	132.0	-28.04%
Fresenius Medical Care Ag	Hold	$13.8B	-38.54%	24.53	2.78%
Hca Holdings, Inc.	Buy	$77.5B	167.3%	14.15	8.16%
Universal Health Services Inc.	Hold	$11.3B	51.23%	10.45	7.22%
Davita Healthcare Partners Inc.	Hold	$11.4B	83.43%	13.32	7.31%
Tenet Healthcare Corp.	Buy	$11.7B	459.88%	3.75	15.48%

About Cryo-cell International

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Organization	Cryo-cell International
Employees	82
CEO	Mr. Mark L. Portnoy
Industry	Services to the Health Industry

Management People of Cryo-cell International

Name	Title
Mr. David I. Portnoy	Chairman & Co-CEO
Mr. Mark L. Portnoy	Co-CEO & Director
Ms. Jill M. Taymans	CFO & VP of Finance
Mr. Oleg Mikulinsky	Chief Information Officer
Dr. Joanne Kurtzberg M.D.	Medical Director and Member of Medical & Scientific Advisory Board

Important FAQs about investing in CCEL Stock from India :

What is Cryo-cell International share price today?

Cryo-cell International share price today stands at $7.12, Open: $6.75 ; Previous Close: $6.60 ; High: $7.31 ; Low: $6.31 ; 52 Week High: $9.50 ; 52 Week Low: $5.12.

The stock opens at $6.75, after a previous close of $6.60. The stock reached a daily high of $7.31 and a low of $6.31, with a 52-week high of $9.50 and a 52-week low of $5.12.

Can Indians buy Cryo-cell International shares?

Yes, Indians can invest in the Cryo-cell International (CCEL) from India.

With INDmoney, you can buy Cryo-cell International at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cryo-cell International at zero transaction cost.

How can I buy Cryo-cell International shares from India?

It is very easy to buy Cryo-cell International from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cryo-cell International (CCEL) be purchased?

Yes, you can buy fractional shares of Cryo-cell International with INDmoney app.

What are the documents required to start investing in Cryo-cell International stocks?

To start investing in Cryo-cell International, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.